In hopes of challenging Incyte’s…
In hopes of challenging Incyte’s topical JAK inhibitor Opzelura, Pfizer [...]
In her inaugural earnings call as…
In her inaugural earnings call as the new CEO of [...]
Alnylam’s stock price plummeted…
Alnylam’s stock price plummeted as much as 29% Thursday morning [...]
The FDA has rebuked Viatris for a…
The FDA has rebuked Viatris for a direct-to-consumer video that [...]
Eli Lilly has doubled down on its…
Eli Lilly has doubled down on its partnership with CDMO [...]
With increased sales of its newer…
With increased sales of its newer drugs compensating for declining [...]
The U.K. pharma marketing watchdog…
The U.K. pharma marketing watchdog has slammed AGB Pharma for [...]
Havas Lynx has shaken up the…
Havas Lynx has shaken up the leadership of its New [...]
Gilead’s “Up to Date” campaign…
Gilead’s “Up to Date” campaign features comedians Nicole Byer and [...]
Some five months after announcing…
Some five months after announcing the planned retirement of its [...]